Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease
暂无分享,去创建一个
Ehsan Ullah | Khalid Kunji | Mohamad Saad | A. El-Menyar | J. Al Suwaidi | V. Mohamed-ali | Reem Elsousy | M. Al-Nesf | Mohammed Al‐Maadheed | H. R. Mokhtar | Eiman Ahmad | A. Beotra
[1] Vardhan Shorewala,et al. Early detection of coronary heart disease using ensemble techniques , 2021, Informatics in Medicine Unlocked.
[2] Francesca N. Delling,et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. , 2021, Circulation.
[3] L. Cowart,et al. Sphingolipids in the Heart: From Cradle to Grave , 2020, Frontiers in Endocrinology.
[4] Shuzhao Li,et al. MetaboAnalystR 3.0: Toward an Optimized Workflow for Global Metabolomics , 2020, Metabolites.
[5] Gregory B. Lim. Sphingolipids are biomarkers of coronary disease , 2020, Nature Reviews Cardiology.
[6] I. Kullo,et al. Discovering Novel Biochemical and Genetic Markers for Coronary Heart Disease in Qatari Individuals: The Initiative Qatar Cardiovascular Biorepository , 2020, Heart views : the official journal of the Gulf Heart Association.
[7] Marianne K Henderson,et al. Qatar Biobank Milestones in Building a Successful Biobank. , 2019, Biopreservation and biobanking.
[8] S. Hunt,et al. Machine Learning Reveals Serum Sphingolipids as Cholesterol-Independent Biomarkers of Coronary Artery Disease. , 2019, The Journal of clinical investigation.
[9] Minoru Kanehisa,et al. Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.
[10] A. Menotti,et al. Epidemiology of Heart Disease of Uncertain Etiology: A Population Study and Review of the Problem , 2019, Medicina.
[11] D. Wishart,et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure , 2019, Cardiovascular Diabetology.
[12] E. Boerwinkle,et al. Metabolomic Pattern Predicts Incident Coronary Heart Disease. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[13] M. Su,et al. Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data , 2017, bioRxiv.
[14] Min-Jeong Shin,et al. Alterations in Circulating Amino Acid Metabolite Ratio Associated with Arginase Activity Are Potential Indicators of Metabolic Syndrome: The Korean Genome and Epidemiology Study , 2017, Nutrients.
[15] R. Hajar. Risk Factors for Coronary Artery Disease: Historical Perspectives , 2017, Heart views : the official journal of the Gulf Heart Association.
[16] M. Young,et al. Metabolic Origins of Heart Failure , 2017, JACC. Basic to translational science.
[17] E. Gao,et al. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction. , 2016, American journal of physiology. Heart and circulatory physiology.
[18] J. Pernow,et al. Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction , 2016, Diabetes & vascular disease research.
[19] R. Gerszten,et al. Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension , 2016, Circulation.
[20] B. Climént,et al. Tissue‐specific up‐regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus , 2015, British journal of pharmacology.
[21] Sonia Borodzicz,et al. Sphingolipids in cardiovascular diseases and metabolic disorders , 2015, Lipids in Health and Disease.
[22] R. Caldwell,et al. Arginase: an old enzyme with new tricks. , 2015, Trends in pharmacological sciences.
[23] Max Kuhn,et al. caret: Classification and Regression Training , 2015 .
[24] André M Deelder,et al. A metabolomic profile is associated with the risk of incident coronary heart disease. , 2014, American heart journal.
[25] M. Copetti,et al. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects. , 2014, Atherosclerosis.
[26] R. Gerszten,et al. A Plasma Long‐Chain Acylcarnitine Predicts Cardiovascular Mortality in Incident Dialysis Patients , 2013, Journal of the American Heart Association.
[27] Torsten Doenst,et al. Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production , 2013, Circulation research.
[28] R. Tian,et al. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. , 2013, Circulation research.
[29] Yibin Wang,et al. Branched chain amino acid metabolic reprogramming in heart failure. , 2013, Biochimica et biophysica acta.
[30] C. Jung,et al. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? , 2013, Cardiovascular research.
[31] S. Chandra,et al. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. , 2013, Cardiovascular research.
[32] W. Kraus,et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. , 2012, American heart journal.
[33] W. März,et al. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. , 2011, Atherosclerosis.
[34] David S. Wishart,et al. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..
[35] Geoffrey S Ginsburg,et al. Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events , 2010, Circulation. Cardiovascular genetics.
[36] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[37] Geoffrey S Ginsburg,et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease , 2009, Molecular systems biology.
[38] M. Bartoli,et al. Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity , 2008, Circulation research.
[39] W. Durante,et al. ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION , 2007, Clinical and experimental pharmacology & physiology.
[40] J. Kastelein,et al. Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease , 2007, Diabetes, obesity & metabolism.
[41] Michael J Pencina,et al. Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study , 2007, Circulation.
[42] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[43] W. Durante,et al. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[44] Winston,et al. Obesity : impact on cardiovascular disease , 1998, Circulation.
[45] R. Cannon. Role of nitric oxide in cardiovascular disease: focus on the endothelium. , 1998, Clinical chemistry.
[46] F. Vaz,et al. Acylcarnitines: reflecting or inflicting insulin resistance? , 2013, Diabetes.
[47] Olga Ilkayeva,et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.
[48] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[49] M. Szpetnar,et al. Branched chain amino acids (BCAAs) in heart diseases (ischaemic heart disease and myocardial infarction). , 2004, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina.